COMPOUNDS / STIMULANT / ALPHA-PHP
STIMULANT

ALPHA-PHP

HIGH RISK
BEST FOR:Stimulation○○○○○○○○○○0/10
ALPHA-PHP · Α-PHP · A-PHP · ALPHA-PYRROLIDINOHEXANOPHENONE · Α-PYRROLIDINOHEXIOPHENONE · ALPHA-PYRROLIDINOHEXIOPHENONE
Synthetic CathinonePyrovaleroneNPSDesigner DrugDopamine Reuptake Inhibitor

Synthetic cathinone and pyrovalerone derivative acting as a potent dopamine reuptake inhibitor with high abuse liability.

ROUTE / DOSAGE
LOW5mg
STANDARD10-25mg
HIGH40mg+
Note: Slower onset due to first-pass metabolism; longer duration than other routes
CYCLE
Avoid redosing single session only no daily use
BIOAVAILABILITY
~50% oral ~75% intranasal ~90% inhalation
ACTIVE DURATION
3-6h (subjective)
STORAGE
Room temperature dry away from light
HALF-LIFE
~14-18h (plasma)
DURATION BREAKDOWN
Total3-6h
Onset2-30min
Come up15-30min
Peak1-3h
Offset1-2h
After effects2-6h
Duration varies by route, dose, and individual. Source: community reports.
§ 01 — EFFECTS
8 documented
Strong central stimulation
Euphoria and elevated mood
Increased alertness and wakefulness
Tachycardia and hypertension
Agitation and aggressive behavior
Hyperthermia and sweating
Analgesia
Hallucinations at high doses
§ 02 — RISKS
Fatal intoxications have been documented in forensic case series
Severe cardiovascular toxicity including tachycardia, tachypnoea, and thoracic pain
Psychiatric adverse effects including psychomotor agitation, aggression, and hallucinations
Rhabdomyolysis and hyperthermia requiring emergency treatment
Neurologic adverse effects including tremors and fasciculations
High potential for compulsive redosing and dependence due to rapid onset and short duration
§ 03 — INTERACTIONS
No interaction with your stack
VIEW STACK
CAUTION
Alcohol
MXE
Dissociatives
AVOID · DANGEROUS
25x-NBOMe
25x-NBOH
Tramadol
SNRIs
MAOIs
Serotonin releasers
SSRIs
5-HTP
DXM
MDMA
Stimulants
§ 04 — SCIENCE

Alpha-PHP is a synthetic cathinone from the pyrovalerone derivative subgroup, structurally related to alpha-PVP (flakka) as its one-carbon homolog. In vitro studies confirm it is at least as potent as alpha-PVP at inhibiting dopamine reuptake, with most analogues showing narrow potency ranges and high DAT selectivity. Forensic case series (29 and 33 cases respectively) document serum concentrations ranging from 1 to 83 ng/mL and 0.75 to 128 µg/L, with nearly universal poly-drug co-consumption including opiates, benzodiazepines, and cannabinoids. Clinical case reports from poison control centers describe severe toxidromes including psychomotor agitation, hallucinations, tachycardia, hyperthermia, and rhabdomyolysis. Animal studies reveal sex-related differences in pharmacokinetics and behavioral effects, with female mice showing greater sensitivity to sensory and thermoregulatory effects. Evidence remains limited to forensic case reports and preclinical studies, with no controlled human pharmacological trials.

§ 06 — SOURCES
[1]
Alpha-PHP and Alpha-PiHP: A Review (PMID 38672701)
pubmed.ncbi.nlm.nih.gov ↗
[2]
Alpha-PHP vs Alpha-PiHP: Toxicological investigation of plasma concentrations and behavior (PMID 38491987)
pubmed.ncbi.nlm.nih.gov ↗
[3]
Pyrrolidinyl Synthetic Cathinones Alpha-PHP and 4F-alpha-PVP Metabolite Profiling (PMID 33379373)
pubmed.ncbi.nlm.nih.gov ↗
[4]
Structure-Activity Relationships for Alpha-PHP as DAT Reuptake Inhibitor (PMID 37406364)
pubmed.ncbi.nlm.nih.gov ↗
[5]
Alpha-PHP: Acute effects and pharmacokinetic in mice, and clinical intoxication data (PMID 39987764)
pubmed.ncbi.nlm.nih.gov ↗
[6]
In vitro metabolic studies and machine learning analysis for differentiating alpha-PHP and alpha-PiHP (PMID 38996540)
pubmed.ncbi.nlm.nih.gov ↗
[7]
Toxicological Investigation of Case Series Involving Alpha-PHP and Metabolite Identification (PMID 35921233)
pubmed.ncbi.nlm.nih.gov ↗
[8]
PsychonautWiki - A-PHP
psychonautwiki.org ↗
Disclaimer. Protokol.wiki is an informational reference. Nothing on this site is medical advice. Compounds listed may be unapproved, unregulated, or illegal in your jurisdiction. Consult a licensed physician before use. Data compiled from peer-reviewed literature.
METHODOLOGYCONTRIBUTECONTACT